BDS
BIO icon

Banco de Sabadell’s Bio-Rad Laboratories Class A BIO Stock Holding History

Banco de Sabadell’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-250
Closed -$142K – 145
2021
Q1 		$142K Hold
250
– – 0.01% 227
2020
Q4 		$144K Buy
250
+120
+92% +$68.3K 0.02% 246
2020
Q3 		$67K Hold
130
– – 0.01% 307
2020
Q2 		$57K Buy
+130
New +$57.4K 0.01% 263

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Banco de Sabadell's BIO Position: Q2 2021 in Review

Banco de Sabadell sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 250 shares — an estimated $142K sold.

Banco de Sabadell first reported a position in BIO in Q2 2020 and held it in 4 quarters. The position peaked at $144K in Q4 2020. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • Banco de Sabadell reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
  • Banco de Sabadell sold 250 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $142K.
  • Banco de Sabadell first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 4 quarters.
  • Banco de Sabadell's Bio-Rad Laboratories Class A position peaked at $144K in Q4 2020.
  • 509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on Banco de Sabadell's 13F filing for Q2 2021, filed 13 Aug 2021.